Unable to write in log file ../../bases/logs/gimorg/logerror.txt Search | WHO COVID-19 Research Database
Show: 20 | 50 | 100
Results 1 - 20 de 233
American Journal of Gastroenterology ; 117(10):S1253-S1253, 2022.
Article in English | Web of Science | ID: covidwho-2310329
Gastroenterology ; 164(4 Supplement):S15, 2023.
Article in English | EMBASE | ID: covidwho-2306267
European Journal of Molecular and Clinical Medicine ; 7(11):9418-9421, 2020.
Article in English | EMBASE | ID: covidwho-2303773
Pharmaceuticals: Boon or Bane ; : 69-89, 2023.
Article in English | Scopus | ID: covidwho-2261636
Asian Journal of Pharmaceutical and Clinical Research ; 16(3):124-127, 2023.
Article in English | EMBASE | ID: covidwho-2260825
European Respiratory Journal Conference: European Respiratory Society International Congress, ERS ; 60(Supplement 66), 2022.
Article in English | EMBASE | ID: covidwho-2249031
Inflammatory Bowel Diseases ; 29(Supplement 1):S11, 2023.
Article in English | EMBASE | ID: covidwho-2288180
Journal of Datta Meghe Institute of Medical Sciences University ; 17(4):904-910, 2022.
Article in English | Scopus | ID: covidwho-2281200
New Zealand Economic Papers ; 2023.
Article in English | Scopus | ID: covidwho-2274286
Journal of the American College of Cardiology ; 81(8 Supplement):1740, 2023.
Article in English | EMBASE | ID: covidwho-2272505
Journal of the American College of Cardiology ; 81(8 Supplement):3468, 2023.
Article in English | EMBASE | ID: covidwho-2271629
Pharmacy Education ; 20(3):22.0, 2020.
Article in English | EMBASE | ID: covidwho-2234216


Background: The World Health Organisation sent a clear message to the world, to 'test, test, and test' for early identification, isolation, and limiting the spread of coronavirus disease 2019 (COVID-19). Dismal testing rates have been the biggest barrier to understanding the spread of this disease. Community pharmacists and pharmacies provide an accessible and reliable avenue to increase testing rates. Purpose(s): To identify opportunities and barriers to implementing COVID-19 testing in community pharmacies. Method(s): Review of worldwide literature from 2019 and onwards was completed to review guidance documents and expert opinions on COVID-19 testing by community pharmacists. Result(s): So far, only 32 states in the USA have provided community pharmacists with the independent ability to order and administer COVID-19 tests in community pharmacies. Opportunities are: fast and reliable access to testing;improved testing rate, data collection, and patient-pharmacists relationships;provide personalised follow-ups and new services;and leverage opportunity for future government collaboration. Barriers are: government buy-in, regulations and bylaw compliance, training, personal protective equipment, staffing needs, workflow optimisation, processes for collaboration with public health authorities, and pharmacists' willingness. Conclusion(s): COVID-19 testing in community pharmacies can improve testing rates, and provide new avenues to collaborate on public health initiatives. There is a scarcity of evidence and literature around this topic and future work should explore success of testing in community pharmacies, and pharmacists and public perceptions of provision of such services in community pharmacy setting.

Pharmacy Education ; 20(3):59.0, 2020.
Article in English | EMBASE | ID: covidwho-2228138


Background: From December 2019, the healthcare system as we know it changed, as the WHO declared a worldwide COVID-19 outbreak. Purpose(s): Evidenced-based review of pharmacy emergency major incident plan, alongside internationally recognised policies, with government updates (Ministry of Public Health;2019;ASHP, 2020;GPhC, 2020;Ministry of Public Health;2020);RPS, 2020). Method(s): Pharmacy leadership identified staff who could work remotely, split shifts;receive cross training. The clinical team worked closely with the infectious disease/antimicrobial stewardship team towards devising a clinical plan to manage those under our care. Result(s): Service changes included: team members resorted to online or telephone discussions;verification of medication orders took place from home;activation of automation systems;changes to the pharmacy homecare service;communication moved to digital virtual platforms;measures such as the addition of floor markings and medication deliveries to clinics were implemented. Patient education leaflets and social media platforms were utilised to inform patients. Introduction of a drive-through pharmacy collection service, home delivery services, online medication request services, along with expansion of the telephone request infrastructure. Tailored 'ABC' analysis were performed to identify 'valuable' medicine. Non-formulary stocks were distributed to all patients, to prevent any panic or assumption about shortage. All 2021 medication supply plan was booked with manufacturers. The Pharmacy Director was able to create new 'just-in time' delivery channels. Conclusion(s): It is important to reach out to approved evidenced-based guidance, and services must change in order to maintain high level patient care within a crisis. The question now arises-iIs there a need for further improvement?'.

Journal of Pharmaceutical Negative Results ; 14:27-33, 2023.
Article in English | EMBASE | ID: covidwho-2218297